In other words HTDS does not need to dilute and sell stock to stay in business, as many other companies do. We remind our followers that HTDS was a company in duress some 18 months ago. Today, all of its debts and obligations have been repaid. See Pink Sheet filing

"The company was deemed administratively abandoned by its former officers and directors.

Current management acquired control of the corporation through purchase of preferred shares from Shareholder Advocates in December, 2008"

The hardship and duress days are well behind HTDS now. As with most other financial vehicles the values are driven by confidence. HTDS management is aware that this organized stock basher group, see www.stock-bashers, are planting ridiculous and unwarranted doubt with novice and unsuspecting shareholders of HTDS, thus attempting to destroy confidence. At some point in the near future management of HTDS knows that sanity and panic driven tactics will simply not work anymore. At some point prudent investors will look at HTDS and ask what is wrong with this picture? The answer is nothing is wrong! The share price is extremely undervalued. HTDS is a thriving little company with a lot of potential. It has been unfairly targeted by naked short sellers and their cronies. If your question is why, and why the sudden surge? The answer is simple. In early January HTDS will be heard in a court motion in front of a master in Toronto will sign a formal 10 million dollar default judgement HTDS won as a co beneficiary in a slander lawsuit against a chat board Investors Hub. HTDS has already been awarded costs judgement in the amount of $14,000. As one can see these stock bashers and their employer(s) have a lot of motives.

As a company HTDS continues to operate as a going concern on solid ground and continuing with our aspirations of either merging with a stem cell company, or starting our own. We continue with our daily business activities, the research into MS, Lung cancer with our www.mindupbioresearch project to name a few. The company has placed a valuation of itself of 150 million dollars. The company is not ruling out a 1 to 4 billion share buyback program to affirm its values. At some point in time HTDS may re point its resources away from research and development towards share purchase of its security. The opportunities that HTDS makes available are not only in the medical sector but in the financial as well. HTDS management will not stand idle without acting on the an opportunity available. There are financial backers who acknowledge HTDS' values and the company firmly stand by its beliefs and its values.

HTDS remains a vibrant, well capitalized, well run company determined to overcome the abuses faced.